1 |
Abdelrahman A, Negroni C, Sahm F, Adams CL, Urbanic-Purkart T, Khalil M, Vergura R, Morelli C, Hanemann CO. miR-497 and 219 in blood aid meningioma classification. J Neurooncol 2022. [PMID: 36076132 DOI: 10.1007/s11060-022-04126-0] [Reference Citation Analysis]
|
2 |
Zhang J, Liu Z, Dong Y, Bukhari I. miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/6423237] [Reference Citation Analysis]
|
3 |
Carlos-Escalante JA, Paz-López ÁA, Cacho-Díaz B, Pacheco-Cuellar G, Reyes-Soto G, Wegman-Ostrosky T. Primary Benign Tumors of the Spinal Canal. World Neurosurg 2022;164:178-98. [PMID: 35552036 DOI: 10.1016/j.wneu.2022.04.135] [Reference Citation Analysis]
|
4 |
Jiang H, Zeng W, Zhang X, Pei Y, Zhang H, Li Y. The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study. Bioengineered 2022;13:7847-59. [PMID: 35291914 DOI: 10.1080/21655979.2022.2049959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Carneiro V, Cirino M, Panepucci R, Peria F, Tirapelli D, Colli B, Carlotti CG Jr. The Role of MicroRNA 181d as a Possible Biomarker Associated With Tumor Progression in Meningiomas. Cureus 2021;13:e19158. [PMID: 34873501 DOI: 10.7759/cureus.19158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
6 |
Duba M, Rošková I, Mrlian A, Fadrus P, Vybíhal V, Kazda T, Al Tukmachi D, Šána J, Hrdý O, Duba J, Smrčka M. Surgical treatment of brain metastases. Onkologie 2021;15:231-237. [DOI: 10.36290/xon.2021.044] [Reference Citation Analysis]
|